Literature DB >> 12161

Control of phosphofructokinase from rat skeletal muscle. Effects of fructose diphosphate, AMP, ATP, and citrate.

K Tornheim, J M Lowenstein.   

Abstract

Under conditions used previously for demonstrating glycolytic oscillations in muscle extracts (pH 6.65, 0.1 to 0.5 mM ATP), phosphofructokinase from rat skeletal muscle is strongly activated by micromolar concentrations of fructose diphosphate. The activation is dependent on the presence of AMP. Activation by fructose diphosphate and AMP, and inhibition by ATP, is primarily due to large changes in the apparent affinity of the enzyme for the substrate fructose 6-phosphate. These control properties can account for the generation of glycolytic oscillations. The enzyme was also studied under conditions approximating the metabolite contents of skeletal muscle in vivo (pH 7.0, 10mM ATP, 0.1 mM fructose 6-phosphate). Under these more inhibitory conditions, phosphofructokinase is strongly activated by low concentrations of fructose diphosphate, with half-maximal activation at about 10 muM. Citrate is a potent inhibitor at physiological concentrations, whereas AMP is a strong activator. Both AMP and citrate affect the maximum velocity and have little effect on affinity of the enzyme for fructose diphosphate.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 12161

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Calcium and glycolysis mediate multiple bursting modes in pancreatic islets.

Authors:  Richard Bertram; Leslie Satin; Min Zhang; Paul Smolen; Arthur Sherman
Journal:  Biophys J       Date:  2004-09-03       Impact factor: 4.033

2.  Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis.

Authors:  Jiansheng Xie; Chunyan Dai; Xun Hu
Journal:  J Biol Chem       Date:  2016-02-25       Impact factor: 5.157

Review 3.  Fructose and hepatic insulin resistance.

Authors:  Samir Softic; Kimber L Stanhope; Jeremie Boucher; Senad Divanovic; Miguel A Lanaspa; Richard J Johnson; C Ronald Kahn
Journal:  Crit Rev Clin Lab Sci       Date:  2020-01-14       Impact factor: 6.250

4.  Experimental candidiasis in rabbits: protective action of fructose-1,6-diphosphate.

Authors:  R Tarsi; N Simonetti; C Orpianesi
Journal:  Mycopathologia       Date:  1983-02-17       Impact factor: 2.574

5.  Mice deficient in phosphofructokinase-M have greatly decreased fat stores.

Authors:  Lisa Getty-Kaushik; Jason C Viereck; Jessie M Goodman; Zifang Guo; Nathan K LeBrasseur; Ann-Marie T Richard; John N Flanagan; Gordon C Yaney; James A Hamilton; Keith Tornheim
Journal:  Obesity (Silver Spring)       Date:  2009-09-24       Impact factor: 5.002

6.  Subunit interactions and composition of the fructose 6-phosphate catalytic site and the fructose 2,6-bisphosphate allosteric site of mammalian phosphofructokinase.

Authors:  Cristina Ferreras; Eloy D Hernández; Oscar H Martínez-Costa; Juan J Aragón
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

Review 7.  Fructose-1,6-bisphosphate, a regulator of metabolism.

Authors:  M E Kirtley; M McKay
Journal:  Mol Cell Biochem       Date:  1977-12-29       Impact factor: 3.396

8.  Fructose 2,6-bisphosphate in rat skeletal muscle during contraction.

Authors:  Y Minatogawa; L Hue
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

9.  Changes in glucose 1,6-bisphosphate content in rat skeletal muscle during contraction.

Authors:  A M Bassols; J Carreras; R Cussó
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

10.  A model of phosphofructokinase and glycolytic oscillations in the pancreatic beta-cell.

Authors:  Pål O Westermark; Anders Lansner
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.